마이코톡신 검출기 시장 : 세계 예측(2026-2032년)

The Mycotoxin Detector Market is projected to grow by USD 1,218.45 million at a CAGR of 9.54% by 2032.

Mycotoxin Detectors Support Faster, More Targeted Food and Feed Safety Decisions

Mycotoxin detectors identify or quantify toxic fungal metabolites in commodities, ingredients, animal feed, and agricultural products. Their role is expanding as food-safety programs place greater emphasis on traceability, preventive controls, rapid release decisions, and verification across increasingly complex supply chains. Adoption depends on analytical sensitivity, selectivity, ease of use, sample preparation requirements, operator training, and compatibility with laboratory or field workflows.

Food-Safety Complexity Is Shifting Testing Toward Rapid, Distributed Workflows

Climate variability, changing storage conditions, global commodity movement, and stricter quality controls are increasing the need for timely screening. Laboratories continue to require dependable confirmatory methods, while processors, traders, farms, and inspection bodies increasingly value portable or near-line tools that can flag contamination before products move further through the chain. The most durable shift is toward layered testing: rapid screening for operational decisions followed by validated confirmation when results are disputed or regulatory action is possible.

Artificial Intelligence Improves Interpretation, Workflow Control, and Risk Prioritization

Artificial intelligence can strengthen mycotoxin detection by recognizing complex signal patterns, compensating for matrix effects, identifying anomalous samples, and helping prioritize confirmatory testing. It can also support instrument maintenance, automated quality checks, digital chain-of-custody records, and integration with laboratory information systems. However, AI-enabled outputs require representative training data, transparent validation, controlled versioning, and human oversight. Performance may vary across commodities, geographies, instruments, and contamination levels, so deployment should preserve documented analytical controls rather than treat model output as a substitute for validation.

Regional Conditions Shape Where Rapid Mycotoxin Testing Creates the Most Operational Value

North America emphasizes preventive controls, laboratory verification, and traceable supply chains, supporting demand for interoperable screening and confirmatory workflows. Latin America's diverse crop base and export orientation increase the importance of testing at collection, storage, processing, and border points. Europe combines rigorous food and feed controls with strong laboratory infrastructure, favoring validated methods and digital traceability. The Middle East places particular value on imported-food assurance, inspection efficiency, and dependable testing under varied logistics conditions. Africa's priorities include accessible testing, post-harvest loss reduction, and methods suited to decentralized agricultural systems. Asia-Pacific spans advanced analytical environments and rapidly developing food-safety infrastructures, creating demand for scalable tools that accommodate varied commodities, laboratories, and operator capabilities.

Economic and Regulatory Groups Create Distinct Testing Priorities

ASEAN requires approaches that accommodate diverse food systems, cross-border trade, and uneven laboratory capacity. BRICS members face broad commodity, agricultural, and regulatory variation, making adaptable workflows and comparable results especially important. The European Union prioritizes harmonized controls, documented methods, and traceability across member-state supply chains. G7 markets generally emphasize mature quality systems, rigorous validation, and integration with established laboratory networks. GCC countries focus strongly on import assurance, centralized oversight, and rapid release of food and feed consignments. NATO members may benefit from resilient, interoperable testing capabilities that support continuity of supply and standardized procedures across complex logistics environments.

Country Context Determines Deployment Mix, Validation Needs, and User Priorities

Australia's extensive agricultural supply chains support remote and centralized testing models. Brazil's major crop and feed sectors heighten the value of testing across harvest, storage, and export channels. Canada and the United States emphasize preventive controls, laboratory quality, and supply-chain documentation. China and India require scalable approaches suited to large, diverse food systems and varied testing environments. Japan and South Korea place strong emphasis on analytical reliability, process control, and advanced quality assurance. France, Germany, Italy, and Spain operate within demanding European food-safety frameworks, increasing the importance of validated, interoperable workflows. The United Kingdom continues to value traceability, laboratory assurance, and rapid risk management. Mexico's role in regional agriculture and trade supports testing at production, processing, and border interfaces. Russia's broad agricultural geography makes robustness across commodities and operating conditions important.

Industry Leaders Should Build Validated, Interoperable, and User-Centered Testing Programs

Leaders should segment testing by decision point: field screening, intake inspection, process control, release testing, and regulatory confirmation. They should validate performance separately for major commodity matrices, establish clear escalation rules for presumptive positives, and document uncertainty, calibration, controls, and sample handling. Procurement should assess total workflow burden rather than instrument specifications alone, including preparation time, consumables, training, maintenance, connectivity, and data governance. Organizations should also pilot AI features in parallel with established methods, monitor drift, protect result integrity, and connect instruments to traceability systems. Finally, training and proficiency testing should be treated as core controls, especially where testing is distributed across farms, warehouses, processors, and inspection sites.

Methodology Combines Market-Specific Scope With Evidence-Based Analytical Framing

This executive summary defines the mycotoxin detector category around technologies and workflows used to screen, identify, or quantify mycotoxins in relevant agricultural, food, feed, and ingredient samples. The analysis is structured by application context, analytical workflow, operating environment, and geography. Regional, group, and country perspectives are interpreted through documented food-safety requirements, commodity flows, laboratory practices, infrastructure conditions, and technology characteristics. Claims are limited to qualitative, data-backed insights; no market estimates, market shares, forecasts, or company-specific assessments are included. Conclusions should be updated as standards, validated methods, instrument capabilities, and supply-chain risks change.

Reliable Mycotoxin Detection Depends on Matching Analytical Assurance to Operational Decisions

Mycotoxin detectors are most valuable when they are embedded in a risk-based control system rather than deployed as isolated devices. Rapid tools can improve responsiveness and reduce unnecessary movement of suspect material, while laboratory confirmation protects regulatory credibility and commercial trust. Across regions, economic groups, and countries, successful programs will combine fit-for-purpose performance, validated procedures, skilled users, secure data, and clear action thresholds. The strategic priority is therefore not simply acquiring detection equipment, but building a connected, auditable workflow that converts analytical results into timely and defensible food- and feed-safety decisions.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Mycotoxin Detector Market, by Product Type

• 7.1. Introduction
• 7.2. Analytical Instruments
  • 7.2.1. GC-MS
  • 7.2.2. HPLC
  • 7.2.3. LC-MS
• 7.3. Rapid Test Kits
  • 7.3.1. Fluorometric Assays
  • 7.3.2. Lateral Flow Strips

8. Mycotoxin Detector Market, by Technology

• 8.1. Introduction
• 8.2. Biosensor
  • 8.2.1. Electrochemical Biosensors
  • 8.2.2. Optical Biosensors
• 8.3. ELISA
  • 8.3.1. Competitive ELISA
  • 8.3.2. Sandwich ELISA
• 8.4. Lateral Flow Immunoassay
  • 8.4.1. Fluorescent LFIAs
  • 8.4.2. Immunochromatographic Test Strips
• 8.5. PCR
  • 8.5.1. Digital PCR
  • 8.5.2. Real-Time PCR

9. Mycotoxin Detector Market, by Application

• 9.1. Introduction
• 9.2. Clinical Diagnostics
  • 9.2.1. Hospital Labs
  • 9.2.2. Point-Of-Care
• 9.3. Environmental Testing
  • 9.3.1. Air
  • 9.3.2. Soil
  • 9.3.3. Water
• 9.4. Feed Safety
  • 9.4.1. Cattle Feed
  • 9.4.2. Poultry Feed
• 9.5. Food Safety
  • 9.5.1. Dairy
  • 9.5.2. Grain
  • 9.5.3. Meat
  • 9.5.4. Nuts

10. Mycotoxin Detector Market, by End User

• 10.1. Introduction
• 10.2. Contract Research Organizations
• 10.3. Feed Testing Laboratories
• 10.4. Food Testing Laboratories
• 10.5. Research Institutes

11. Mycotoxin Detector Market, by Distribution Channel

• 11.1. Introduction
• 11.2. Direct Sales
• 11.3. Distributors
  • 11.3.1. Regional Distributors
  • 11.3.2. Value-Added Resellers
• 11.4. Online
  • 11.4.1. Company Website
  • 11.4.2. E-Commerce Platforms

12. Mycotoxin Detector Market, by Region

• 12.1. Introduction
• 12.2. Asia-Pacific
• 12.3. North America
• 12.4. Latin America
• 12.5. Europe
• 12.6. Middle East
• 12.7. Africa

13. Mycotoxin Detector Market, by Group

• 13.1. Introduction
• 13.2. ASEAN
• 13.3. GCC
• 13.4. European Union
• 13.5. BRICS
• 13.6. G7
• 13.7. NATO

14. Mycotoxin Detector Market, by Country

• 14.1. Introduction
• 14.2. United States
• 14.3. Canada
• 14.4. Mexico
• 14.5. Brazil
• 14.6. United Kingdom
• 14.7. Germany
• 14.8. France
• 14.9. Russia
• 14.10. Italy
• 14.11. Spain
• 14.12. China
• 14.13. India
• 14.14. Japan
• 14.15. Australia
• 14.16. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2025
• 15.2. Market Concentration Analysis, 2025
  • 15.2.1. Concentration Ratio (CR)
  • 15.2.2. Herfindahl Hirschman Index (HHI)
• 15.3. Recent Developments & Impact Analysis, 2025
• 15.4. Product Portfolio Analysis, 2025
• 15.5. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Agilent Technologies, Inc.
• 16.2. BioTek Instruments, LLC
• 16.3. Bio-Rad Laboratories, Inc.
• 16.4. Bruker Corporation
• 16.5. Charleston Laboratories, Inc.
• 16.6. ELISA Systems GmbH
• 16.7. Envirologix Inc.
• 16.8. Eurofins Scientific SE
• 16.9. F. Hoffmann-La Roche Ltd.
• 16.10. Intertek Group plc
• 16.11. LuminUltra Technologies Ltd.
• 16.12. Merck KGaA
• 16.13. MilliporeSigma
• 16.14. Neogen Corporation
• 16.15. PerkinElmer, Inc.
• 16.16. QIAGEN N.V.
• 16.17. R-Biopharm AG
• 16.18. Romer Labs Division Holding GmbH
• 16.19. SGS Institut Fresenius GmbH
• 16.20. SGS SA
• 16.21. Shimadzu Corporation
• 16.22. Tecan Group Ltd.
• 16.23. Thermo Fisher Scientific Inc.
• 16.24. Waters Corporation
• 16.25. ZEULAB S.L.

17. Key Experts